TheProfitWatch

FULC - Fulcrum Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.81 1.19 (13.51%) --- --- 0.0 (0.0%) 0.18 (2.04%) 0.9 (10.29%) 0.0 (0.0%) 0.0 (0.0%)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.28
Diluted EPS:
-0.28
Basic P/E:
-35.7143
Diluted P/E:
-35.7143
RSI(14) 1m:
100.0
VWAP:
10.0
RVol:
0.9254

Events

Period Kind Movement Occurred At
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57
1m Price decrease 1m 8.79 -0.09 (-1.01%) Oct 15 10:57

Related News